Kerafast Inc., developers of an online platform to facilitate access to unique lab-made bioresearch materials, today announced the availability of the Delta-G-VSV Pseudotyping System for coronavirus ...
CreoSG announced on the 13th that it has finalized the registration of a domestic patent for a Zika virus vaccine using the recombinant VSV (Vesicular Stomatitis Virus) vector system, a core ...
VSV Capital hosted a Demo Day on Nov. 11, spotlighting 13 innovative fintech startups as part of the Global Market Expansion Program (GMEP). Fintech startups' representatives at VSV Capital's Demo Day ...
The rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to the coronavirus disease 2019 (COVID-19) pandemic, which has, to date, claimed more than 6.4 million lives ...
AB-101, an allogeneic, non–genetically modified, natural killer (NK) cell therapy, evaluated as monotherapy or in combination with rituximab in R/R non-Hodgkin lymphoma. This is an ASCO Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results